Ergoteles LLC Absci Corp Transaction History

Ergoteles LLC

  • $68.2 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$1.17 - $2.03 $40,797 - $70,786
34,870 New
34,870 $53,000
Q3 2022

Nov 14, 2022
BUY
$2.95 - $4.83 $158,016 - $258,718
53,565 New
53,565 $168,000
Q1 2022

May 13, 2022
SELL
$5.87 - $9.46 $84,528 - $136,224
-14,400 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$7.88 - $18.03 $113,472 - $259,632
14,400 New
14,400 $118,000

Others Institutions Holding ABSI

# of Institutions
141
Shares Held
62.8M
Call Options Held
255K
Put Options Held
93.6K
View Full List

About Absci Corp

ABSI Quotes by TradingView
  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $457M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Ergoteles LLC Portfolio

Follow Ergoteles LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ergoteles LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email